These results indicate that C-MYC may inhibit tumor immune infiltration in in vivo conditions through inhibiting DAMP (HMGB1) release induced by NCOA4-mediated ferritin autophagy and ferroptosis in ovarian cancer cells. Here, HMGB1 is linked to neoplasm.